The drug maker said that the board of its wholly owned arm, CuraTeQ Biologics (CuraTeQ) has decided to expand its operations by establishing another mammalian cell culture manufacturing facility of higher capacity to cater to the future requirements.
The Unit has contributed Rs6 lakhs income amounting to 0.06% of the total income of the Company during the financial year 2021-22.
Decarbonising Australia’s Mining Sector Beyond Renewables Highlighted in Timely Black & Veatch eBook
The new product will be marketed in the domestic market
Adani Ports and Special Economic Zone rose 1.52% to Rs 850.50 after the companys handled cargo volume increased by 18% YoY to 29.3 MMT in August 2022.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
